Feasibility and Accuracy of a Computer-Assisted Self-Interviewing Instrument to Ascertain Prior Immunization With Human Papillomavirus Vaccine by Self-Report: Cross-Sectional Analysis
- PMID: 32012073
- PMCID: PMC7003116
- DOI: 10.2196/16487
Feasibility and Accuracy of a Computer-Assisted Self-Interviewing Instrument to Ascertain Prior Immunization With Human Papillomavirus Vaccine by Self-Report: Cross-Sectional Analysis
Abstract
Background: Ascertaining history of prior immunization with human papillomavirus (HPV) vaccine can be challenging and resource-intensive. Computer-assisted self-interviewing instruments have the potential to address some of the challenges of self-reporting, and may also reduce the time, costs, and efforts associated with ascertaining immunization status.
Objective: This study assesses both the feasibility and the accuracy of a computer-assisted self-interviewing instrument to ascertain a patient's history of immunization with the HPV vaccine.
Methods: We developed both a survey and a Web-based data collection system using computer-assisted self-interviewing to ascertain self-reported HPV vaccine immunization history. We implemented the instrument in a sample of adult women enrolled in an ongoing study of the HPV vaccine. Vaccine records from prior sources of care were reviewed to verify reported immunization history.
Results: Among the 312 participants who provided HPV vaccine immunization history by self-report, almost all (99%) were able to do so using the computer-assisted self-interviewing instrument. The median survey completion time was 10 minutes (IQR 7-17). The accuracy of self-report was 84%, sensitivity was 89%, specificity was 80%, and the negative predictive value was 92%.
Conclusions: We found that it is feasible to collect a history of immunization with the HPV vaccine using a computer-assisted self-interviewing instrument. This approach is likely to be acceptable to adult women and is reasonably accurate in a clinical research setting.
Keywords: accuracy; computer-assisted self-interviewing; human papillomavirus vaccine; self-report.
©Carlos R Oliveira, Lital Avni-Singer, Geovanna Badaro, Erin L Sullivan, Sangini S Sheth, Eugene D Shapiro, Linda M Niccolai. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 22.01.2020.
Conflict of interest statement
Conflicts of Interest: LMN and SSS have served as Scientific Advisors for Merck. SSS receives Gardasil 9 from Merck at no cost for research.
Figures
References
-
- Markowitz LE, Drolet M, Perez N, Jit M, Brisson M. Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs. Vaccine. 2018 Aug 06;36(32 Pt A):4806–4815. doi: 10.1016/j.vaccine.2018.01.057. https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(18)30117-8 - DOI - PubMed
-
- Williams WW, Lu P, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, Rodriguez-Lainz A, Fiebelkorn AP. Surveillance of Vaccination Coverage among Adult Populations - United States, 2015. MMWR Surveill Summ. 2017 May 05;66(11):1–28. doi: 10.15585/mmwr.ss6611a1. http://europepmc.org/abstract/MED/28472027 - DOI - PMC - PubMed
-
- Centers for Disease ControlPrevention (CDC) Progress in immunization information systems - United States, 2012. MMWR Morb Mortal Wkly Rep. 2013 Dec 13;62(49):1005–8. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6249a4.htm - PMC - PubMed
-
- Oliveira Carlos R. ProQuest Dissertations and Theses. 2019. [2019-12-23]. Estimating the Effectiveness of Human Papillomavirus Vaccine: A Case-Control Study with Bayesian Model Averaging. https://search.proquest.com/openview/75781af182db5bcf38312af047594086/1?....
Grants and funding
LinkOut - more resources
Full Text Sources
